Overview

Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI

Status:
Unknown status

Trial end date:
2018-04-01

Target enrollment:

Participant gender:

Summary

TAVI is increasingly adopted as standard treatment for many subgroups of patients with aortic stenosis. However, due to a lack of data there is yet no TAVI-specific guidance regarding the optimum periinterventional drug regimen. The study evaluates the effect of dual antiplatelet pretreatment on periinterventional embolic cerebral lesions and bleeding complications in patients undergoing transfemoral aortic valve implantation (TF-TAVI).

Phase:

Phase 3

Details

Lead Sponsor:

Charite University, Berlin, Germany

Collaborator:

Prof. Dr. Jochen Fiebach, Center for Stroke Research Berlin (CSB), Charité - Universitaetsmedizin Berlin

Treatments:

Aspirin
Clopidogrel